235 related articles for article (PubMed ID: 1666402)
1. Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
Pattyn SR
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):613-7. PubMed ID: 1666402
[TBL] [Abstract][Full Text] [Related]
2. Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test.
McDermott-Lancaster RD; Banerjee DK
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):605-8. PubMed ID: 8151193
[TBL] [Abstract][Full Text] [Related]
3. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
Beskid G; Prosser BL
Am J Med; 1993 Mar; 94(3A):2S-8S. PubMed ID: 8383919
[TBL] [Abstract][Full Text] [Related]
4. Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice.
Franzblau SG; Parrilla ML; Chan GP
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):66-9. PubMed ID: 8392100
[TBL] [Abstract][Full Text] [Related]
5. Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice.
Gelber RH; Iranmanesh A; Murray L; Siu P; Tsang M
Antimicrob Agents Chemother; 1992 Nov; 36(11):2544-7. PubMed ID: 1336951
[TBL] [Abstract][Full Text] [Related]
6. [The serum bactericidal activity of domestic fleroxacin and lomefloxacin].
Zhao M; Jiang S; Wang R
Zhonghua Nei Ke Za Zhi; 1999 Feb; 38(2):98-100. PubMed ID: 11798634
[TBL] [Abstract][Full Text] [Related]
7. The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.
Burgos J; de la Cruz E; Paredes R; Andaya CR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):253-8. PubMed ID: 22125933
[TBL] [Abstract][Full Text] [Related]
8. Determination of the minimal effective dosages of ofloxacin and sparfloxacin against M. leprae in the mouse foot pad system.
Traore I; Ji B; Lienhardt C; Bobin P; Grosset J
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):142-5. PubMed ID: 8690973
[TBL] [Abstract][Full Text] [Related]
9. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Fernandes PB; Swanson RN
Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
[TBL] [Abstract][Full Text] [Related]
10. Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
Guelpa-Lauras CC; Perani EG; Giroir AM; Grosset JH
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):70-7. PubMed ID: 3549940
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
[TBL] [Abstract][Full Text] [Related]
12. Activity of sparfloxacin against Mycobacterium leprae inoculated into footpads of nude mice.
Gidoh M; Tsutsumi S
Lepr Rev; 1992 Jun; 63(2):108-16. PubMed ID: 1322480
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of five quinolones against Chlamydia pneumoniae.
Hammerschlag MR; Hyman CL; Roblin PM
Antimicrob Agents Chemother; 1992 Mar; 36(3):682-3. PubMed ID: 1320366
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activities of newly developed quinolones, fleroxacin, lomefloxacin and sparfloxacin against Mycobacterium tuberculosis].
Kawahara S; Kamisaka K; Tada A; Nakada H; Mishima Y; Yoshimoto S; Matsuyama T; Kibata M; Nagare J
Kekkaku; 1991 Jun; 66(6):429-31. PubMed ID: 1942726
[TBL] [Abstract][Full Text] [Related]
15. Cross-resistance and cross-susceptibility between fluoroquinolone agents.
Barry AL; Fuchs PC
Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1013-8. PubMed ID: 1666360
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
Ji B; Perani EG; Petinon C; Grosset JH
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
[TBL] [Abstract][Full Text] [Related]
17. Ofloxacin for the treatment of leprosy.
Ji B; Grosset J
Acta Leprol; 1991; 7(4):321-6. PubMed ID: 1950440
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
Barry AL; Jones RN
J Antimicrob Chemother; 1989 Apr; 23(4):527-35. PubMed ID: 2745259
[TBL] [Abstract][Full Text] [Related]
19. Activity of ofloxacin against Mycobacterium leprae in the mouse.
Grosset JH; Guelpa-Lauras CC; Perani EG; Beoletto C
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):259-64. PubMed ID: 3045223
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
